ArticleRSC advances2026
Microplasma-assisted green synthesis of glucose-stabilized silver nanoparticles: a dual-functional platform for SERS detection and synergistic reduction of binary dyes.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A rapid and environmentally sustainable approach for synthesizing glucose-stabilized silver nanoparticles (G-AgNPs) was developed using an atmospheric-pressure microplasma process that completely eliminates the need for conventional chemical reductants and surfactants. The synergistic interaction between plasma-generated reactive species and glucose molecules enabled the one-step formation of uniformly dispersed AgNPs exhibiting dual morphologies-spherical (∼8 nm) and hexagonal (∼16 nm)-with distinct localized surface plasmon resonances (LSPR) centered at ∼403 nm. These nanostructures produced abundant electromagnetic "hot spots," functioning as highly sensitive and reproducible SERS substrates capable of detecting Rhodamine 6G at concentrations as low as 10
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.